Catherine Owen Adams has served as ACADIA's Chief Executive Officer and as a member of the Board of Directors since September 2024, succeeding Stephen R. Davis. She brings more than 25 years of biopharmaceutical leadership. Previously she was Senior Vice President and General Manager, U.S. at Bristol Myers Squibb (2019-2024), where she led a $20 billion commercial business across Oncology, Cardiovascular and Immunology, and earlier served as Senior Vice President, Head of Major Markets at BMS during its merger with Celgene. Before BMS she spent 25 years at Johnson & Johnson, culminating as President, Janssen Immunology U.S. She currently serves on the boards of Agios Pharmaceuticals and AssistRx, and earned a BSc in Pharmacy from the University of Manchester.